Skip to content

WASHINGTON UNIVERSITY

Follow

13F filer, CIK 903603, ST LOUIS, MO

WASHINGTON UNIVERSITY reported $264,794,776 across 3 holdings for the quarter ended 2026-06-30, in a 13F-HR filed 2026-07-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000903603-26-000005

Period
2026-06-30
Reported value
$265M
Holdings
3
Top 10 weight
100%
New
2
Sold out
1

Largest buys vs the previous quarter

SecurityShares changeApprox. value
CBRSnew+551,086$122M
RBRKnew+22,803$1.83M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
MAZEexited-280,802-$8.38M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2026

Share positions as resolved from 13F-HR 0000903603-26-000005, largest first. % of portfolio is the value over $264,794,776, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
NUNU HLDGS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: 10,408,196 shares; 2024Q4: 10,408,196 shares; 2025Q1: 10,408,196 shares; 2025Q2: 10,408,196 shares; 2025Q3: 10,566,927 shares; 2025Q4: 10,566,927 shares; 2026Q1: 10,566,927 shares; 2026Q2: 10,566,927 shares 10,566,927$141M53.31%0Timeline
CBRSCEREBRAS SYSTEMS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 551,086 shares 551,086$122M45.99%newTimeline
RBRKRUBRIK INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,488 shares; 2026Q1: not reported; 2026Q2: 22,803 shares 22,803$1.83M0.69%newTimeline

Sold out in Q2 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MAZEMAZE THERAPEUTICS INC280,802$8.38Mshares

How Q2 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000903603-26-000005 base2026-07-14acceptance time not in the bulk data set

Filings

Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.

FilingSubjectFiledAcceptedIngested
13F-HR 0000903603-26-000005 Quarter ended 2026-06-302026-07-14acceptance time not in the bulk data set
13F-HR 0000903603-26-000003 Quarter ended 2026-03-312026-05-06acceptance time not in the bulk data set
13F-HR 0000903603-26-000002 Quarter ended 2025-12-312026-01-16acceptance time not in the bulk data set
13F-HR 0000903603-25-000007 Quarter ended 2025-09-302025-11-03acceptance time not in the bulk data set
13F-HR 0000903603-25-000004 Quarter ended 2025-06-302025-07-18acceptance time not in the bulk data set
13F-HR 0000903603-25-000003 Quarter ended 2025-03-312025-05-05acceptance time not in the bulk data set
13F-HR 0000903603-25-000002 Quarter ended 2024-12-312025-01-24acceptance time not in the bulk data set
13F-HR 0000903603-24-000007 Quarter ended 2024-09-302024-10-29acceptance time not in the bulk data set
13F-HR 0000903603-24-000005 Quarter ended 2024-06-302024-08-05acceptance time not in the bulk data set
13F-HR 0000903603-24-000003 Quarter ended 2024-03-312024-04-29acceptance time not in the bulk data set
13F-HR 0000903603-24-000001 Quarter ended 2023-12-312024-01-25acceptance time not in the bulk data set
13F-HR 0000903603-23-000005 Quarter ended 2023-09-302023-11-09acceptance time not in the bulk data set
13F-HR 0000903603-23-000004 Quarter ended 2023-06-302023-08-09acceptance time not in the bulk data set
13F-HR 0000903603-23-000003 Quarter ended 2023-03-312023-05-11acceptance time not in the bulk data set
13F-HR 0000903603-23-000001 Quarter ended 2022-12-312023-01-30acceptance time not in the bulk data set
13F-HR 0000903603-22-000005 Quarter ended 2022-09-302022-11-14acceptance time not in the bulk data set
13F-HR 0000903603-22-000004 Quarter ended 2022-06-302022-08-11acceptance time not in the bulk data set
13F-HR 0000903603-22-000003 Quarter ended 2022-03-312022-05-12acceptance time not in the bulk data set
13F-HR 0000903603-22-000002 Quarter ended 2021-12-312022-02-11acceptance time not in the bulk data set
13F-HR 0000903603-21-000009 Quarter ended 2021-09-302021-11-12acceptance time not in the bulk data set
13F-HR 0000903603-21-000008 Quarter ended 2021-06-302021-08-13acceptance time not in the bulk data set
13F-HR 0000903603-21-000006 Quarter ended 2021-03-312021-05-13acceptance time not in the bulk data set
13F-HR 0000903603-21-000002 Quarter ended 2020-12-312021-02-12acceptance time not in the bulk data set